MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO MISSION (US) 3.5/26; CORONARY DRUG-ELUTING STENT

Model Number	453959
Medical Device Problem Code	Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes	Chest Pain (1776); Thrombosis/Thrombus (4440)
Date of Event	10/02/2024
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
Combination product: yes.
Event or Problem Description
An orsiro mission drug-eluting stent system was selected for treatment of the proximal lad.Immediately after procedure an in-stent thrombosis occurred.Patient developed chest pain.Re-ballooning of the stent was performed and additional heparin was given.Patient was treated for heparin-induced thrombocytopenia (hit).Physician shared that during the case the patients act would be 182, give heparin would go to 350 then when re-checked again would be back down to 180.
Additional Manufacturer Narrative
Combination product: yes.The affected product was not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies or other relevant clinical information could not be obtained.Review of the production documentation confirmed that the device in question was manufactured according to specifications and fulfilled all the requirements of in?process and final inspection.Based on the reviewed documentation no device deficiency or manufacturing-related root cause could be identified.Considering the hit-situation of the patient described by the physician, the most probable root cause for the complaint event is the patients anatomy.Please note that, according to the orsiro mission us ifu, administration of appropriate anticoagulant, antiplatelet and vasodilation therapy is critical to successful stent implantation.

• Brand Name: ORSIRO MISSION (US) 3.5/26
• Common Device Name: CORONARY DRUG-ELUTING STENT
• Manufacturer (Section D): BIOTRONIK AG, BUELACH, SWITZERLAND; ackerstrasse 6; buelach CH-81 80; CH CH-8180
• Manufacturer Contact: 6024 jean road; lake oswego, OR 97035 ; 8772459800
• MDR Report Key: 20468091
• Report Number: 1028232-2024-05430
• Device Sequence Number: 7519191
• Product Code: NIQ
• UDI-Device Identifier: 07640130456150
• UDI-Public: (01)07640130456150(17)2606
• Combination Product (Y/N): Y
• Initial Reporter State: KS
• Initial Reporter Country: US
• PMA/510(K) Number: P170030
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2024
• Reporter Type: Manufacturer
• Report Source: User Facility,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 11/07/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Expiration Date: 06/04/2026
• Device Model Number: 453959
• Device Catalogue Number: 453959
• Device Lot Number: 05240712
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 10/07/2024
• Supplement Date Received by Manufacturer: 11/06/2024
• Initial Report FDA Received Date: 10/16/2024
• Supplement Report FDA Received Date: 11/07/2024
• Was Device Evaluated by Manufacturer? (Y/N): Device Not Returned to Manufacturer
• Date Device Manufactured: 06/05/2024
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Hospitalization
• Patient Sex: Unknown